ABEV
Ambev S.A.
NYSE · Consumer Defensive · Beverages - Alcoholic · BR
$3.02
−0.66%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 88.3B | 88.2B | 89.5B | 79.7B | 79.7B |
| Cost of Revenue | 42.5B | 42.9B | 43.6B | 39.3B | 40.4B |
| Gross Profit | 45.8B | 45.4B | 45.8B | 40.4B | 39.3B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 25.1B | 25.1B | 26.4B | 23.4B | 24.0B |
| General & Admin Expense | 5.7B | 5.9B | 6.2B | 5.3B | 5.2B |
| Selling & Marketing Expense | 19.4B | 19.3B | 20.2B | 18.2B | 18.7B |
| Other Expenses | (3.6B) | (2.1B) | (2.4B) | (1.8B) | (2.4B) |
| Total Operating Expenses | 21.5B | 23.1B | 24.0B | 21.6B | 21.6B |
| Cost and Expenses | 63.9B | 65.9B | 67.7B | 60.9B | 62.0B |
| Operating Income (EBIT) | 24.3B | 22.3B | 21.8B | 18.8B | 17.7B |
| Non-Operating | |||||
| Interest Income | 1.6B | 1.4B | 1.6B | 417.6M | 419.7M |
| Interest Expense | 2.7B | 2.7B | 2.4B | 578.4M | 596.1M |
| Net Interest Income | (1.1B) | (1.3B) | (774.3M) | (160.9M) | (176.4M) |
| Other Non-Op Income/Expense | (3.9B) | (2.9B) | (2.3B) | (3.8B) | (3.5B) |
| Non-Operating Income (excl Interest) | 1.2B | 180.2M | (83.8M) | 979.4M | 559.4M |
| EBT (Pre-Tax Income) | 20.4B | 19.4B | 19.5B | 15.0B | 14.2B |
| Income Tax Expense | 3.7B | 3.4B | 4.6B | 75.5M | (655.6M) |
| Bottom Line | |||||
| Net Income | 16.2B | 15.5B | 14.4B | 14.5B | 14.5B |
| Earnings from Cont. Ops | 16.8B | 16.0B | 14.8B | 15.0B | 14.9B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 16.2B | 15.5B | 14.4B | 14.5B | 14.5B |
| Per Share | |||||
| Basic EPS | $1.04 | $0.99 | $0.92 | $0.92 | $0.92 |
| Diluted EPS | $1.04 | $0.99 | $0.91 | $0.92 | $0.91 |
| Revenue Per Share | $5.69 | $5.65 | $5.66 | $5.03 | $5.06 |
| Shares | |||||
| Basic Shares Outstanding | 15.5B | 15.6B | 15.8B | 15.8B | 15.7B |
| Diluted Shares Outstanding | 15.6B | 15.7B | 15.8B | 15.8B | 15.8B |
| Profitability Metrics | |||||
| EBITDA | 29.7B | 29.0B | 29.0B | 24.3B | 23.1B |
| D&A | 6.6B | 6.8B | 7.1B | 6.4B | 6.0B |
| EBIT | 23.1B | 22.1B | 21.9B | 17.9B | 17.1B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026